Prime Medicine, Inc Common Stock
Price & Volume
Stats
See more52W Range | $1.11-$8.27 |
Market Cap | $162.6M |
Shares Short | 18M |
Financials
See moreRevenue (12 Mos) | $2.9M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$152.3M |
Diluted EPS | -$1.65 |
News
See moreYahoo Finance • last month
Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
Yahoo Finance • last year
2 Magnificent Growth Stocks With Room to Run
Yahoo Finance • last year
Prime Medicine to Present at Upcoming Investor Conferences
Yahoo Finance • last year
Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
About
CEO | Dr. Keith Michael Gottesdiener M.D., Ph.D. |
Address | 60 First Street, Cambridge, MA, United States, 02141 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 214 |
